Accuray radiotherapy dose calculation software:
This article was originally published in Clinica
Executive Summary
Accuray has received 510(k) clearance from the US FDA for its dose calculation software for radiotherapy. The technology - called the Monte Carlo Dose calculation algorithm - is now available for sale worldwide, reported the company. Traditional dose calculation methods assume all photons take a single path and therefore use a single calculation to represent the dose delivered by all photons. The Monte Carlo method, however, takes into account interactions of each individual photon when considering an appropriate dose. The Sunnyvale, California firm claims it will be the first company to market the technology. The product was launched at the 9th Biennial European Society for Therapeutic Radiology and Oncology (ESTRO) meeting in Barcelona, Spain, during September 8-13.
You may also be interested in...
Roche Gets Adjuvant ALK+ Lung Cancer To Itself With Alecensa Approval
The US FDA cleared Roche’s supplemental approval request for ALK inhibitor Alecensa in ALK-positive non-small cell lung cancer following tumor resection.
MoCRA’s Adulteration Ambiguity And FDA’s New Cosmetic Recall Authority: Attorney Weighs In
The US FDA should use guidance or rulemaking to clarify MoCRA provisions related to adulteration, Amin Wasserman Gurnani attorney Angela Diesch suggested at the Independent Beauty Association’s Cosmetics Convergence Spring Symposium. Attendees also sought her take on whether the agency’s new recall authority is likely to spell an increase in cosmetic product recalls.
Medtronic Launches Remote Live-Stream Surgery, New AI Capabilities
Medtronic will launch a new feature that allows for live streaming of surgical procedures in more than 20 countries and the addition of 14 AI-driven algorithms to enhance surgical workflow.